Signal Transduction Cascades Controlling Osteoblast Differentiation

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 10-16

  Krause, Carola ^a   De Gorter, David J J ^a   Karperien, Marcel ^b   ten Dijke, Peter ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

catenin; Bone formation; Bone morphogenetic protein; Fibroblast growth factor: IGF; Hedgehog; Notch; Osteoblast; Osterix; nuclear factor for activated T cells; PTH; PTH related peptide; Runx2; Smad; TGF ; WNT

Indexed keywords

EID: 84889270042     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch2     Document Type: Chapter

References (74)

1. Caplan AI, Bruder SP 2001 Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264.
2. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM 2002 Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
3. Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442.
4. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfal, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
5. Mundlos S 1999 Cleidocranial dysplasia: Clinical and molecular genetics. J Med Genet 36:177-182.
6. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein JL, Stein GS 2004 Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14:1-11.
7. Schroeder TM, Jensen ED, Westendorf JJ 2005 Runx2: A master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 75:213-225.
8. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M 1999 Cbfal isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274:6972-6978.
9. Kern B, Shen J, Starbuck M, Karsenty G 2001 Cbfal contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 276:7101-7107.
10. Nishio Y, Dong Y, Paris M, O'Keefe RJ, Schwarz EM, Drissi H 2006 Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372:62-70.
11. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
12. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H 2005 NFAT and Osterix cooperatively regulate bone formation. Nat Med 11:880-885.
13. Urist MR 1965 Bone: Formation by autoinduction. Science 150:893-899.
14. Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233-241.
15. Gazzerro E, Canalis E 2006 Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51-65.
16. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS 2006 A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525-527.
17. Feng XH, Derynck R 2005 Specificity and versatility in TGF-p5 signaling through Smads. Annu Rev Cell Dev Biol 21:659-693.
18. Massague J, Seoane J, Wotton D 2005 Smad transcription factors. Genes Dev 19:2783-2810.
19. Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB 2008 Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 14:14-24.
20. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC 2000 Runx2 is a common target of transforming growth factor pi and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20:8783-8792.
21. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, Hanai J, Nogami H, Ochi T, Miyazono K, Ito Y 2000 A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97:10549-10554.
22. Pereira RC, Rydziel S, Canalis E 2000 Bone morphogenetic pro-tein-4 regulates its own expression in cultured osteoblasts. J Cell Physiol 182:239-246.
23. Ogata T, Wozney JM, Benezra R, Noda M 1993 Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci USA 90:9219-9222.
24. Korchynskyi O, ten Dijke P 2002 Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Idl promoter. J Biol Chem 277:4883-4891.
25. Maeda Y, Tsuji K, Nifuji A, Nöda M 2004 Inhibitory helix-loop-helix transcription factors Idl/Id3 promote bone formation in vivo. J Cell Biochem 93:337-344.
26. Celil AB, Hollinger JO, Campbell PG 2005 Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 95:518-528.
27. Celil AB, Campbell PG 2005 BMP2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353-31359.
28. Janssens K, ten Dijke P, Janssens S, Van Hul W 2005 Transforming growth factor-ßl to the bone. Endocr Rev 26:743-774.
29. Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K 2002 Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J Bone Miner Res 17:1190-1199.
30. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R 2001 TGF-ß-induced repression of CBFA1 by Smad3 decreases cbfal and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20:2254-2272.
31. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K, Ito Y 1999 Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 274:31577-31582.
32. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
33. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R. Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Ee-rdewegh P, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
34. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W 2003 Six novel mis-sense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763-771.
35. van Bezooijen RL, ten Dijke P, Papapoulos SE, Lowik CW 2005 SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 16:319-327.
36. Clevers H 2006 Wnt/ß-catenin signaling in development and disease. Cell 127:469-180.
37. Day TF, Guo X, Garrett-Beal L, Yang Y 2005 Wnt/ß-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750.
38. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C 2005 Canonical Wnt/ß-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738.
39. Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F 2005 Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132:49-60.
40. St Jacques B, Hammerschmidt M, McMahon AP 1999 Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13:2072-2086.
41. Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP 2004 Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131:1309-1318.
42. Hooper JE, Scott MP 2005 Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6:306-317.
43. Hui CC, Joyner AL 1993 A mouse model of greig cephalopoly-syndactyly syndrome: The extra-toesJ mutation contains an intragenic deletion of the Gli3 gene. Nat Genet 3:241-246.
44. Litingtung Y, Dahn RD, Li Y, Fallon JF, Chiang C 2002 Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity. Nature 418:979-983.
45. Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R, Yoneda T 2007 Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18:2411-2418.
46. Rubin MR, Bilezikian JP 2003 New anabolic therapies in osteoporosis. Endocrinol Metab Clin North Am 32:285-307.
47. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289.
48. Miao D, He B, Karaplis AC, Goltzman D 2002 Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109:1173-1182.
49. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE 1996 Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 93:10240-10245.
50. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LH, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM 1996 PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666.
51. Zhang P, Jobert AS, Couvineau A, Silve C 1998 A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 83:3365-3368.
52. Krishnan V, Moore TL, Ma YL, Helvering LM, Frolik CA, Val-asek KM, Ducy P, Geiser AG 2003 Parathyroid hormone bone anabolic action requires Cbfal/Runx2-dependent signaling. Mol Endocrinol 17:423-135.
53. van der Horst G, Farih-Sips H, Lowik CW, Karperien M 2005 Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells. J Bone Miner Res 20:2233-2244.
54. Canalis E, McCarthy TL, Centrella M 1991 Growth factors and cytokines in bone cell metabolism. Annu Rev Med 42:17-24.
55. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B 2001 The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16:2320-2329.
56. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N 2003 Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Aktl and Akt2. Genes Dev 17:1352-1365.
57. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T 2004 Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166:85-95.
58. Ornitz DM 2005 FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16:205-213.
59. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P 2002 The Illc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783-3793.
60. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM 2003 Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130:3063-3074.
61. Franceschi RT, Xiao G 2003 Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
62. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM 2003 The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278:319-326.
63. Ehebauer M, Hayward P, Martinez-Arias A 2006 Notch signaling pathway. Sci STKE 2006:cm7.
64. Zamurovic N, Cappellen D, Rohner D, Susa M 2004 Coordinated activation of notch, Wnt, and transforming growth factor-p signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Heyl inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 279:37704-37715.
65. Deregowski V, Gazzerro E, Priest L, Rydziel S, Canalis E 2006 Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/p-catenin but not bone morphogenetic protein signaling. J Biol Chem 281:6203-6210.
66. Fuentealba LC, Eivers E, Ikeda A. Hurtado C, Kuroda H, Pera EM, De Robertis EM 2007 Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smadl signal. Cell 131:980-993.
67. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J 2007 Balancing BMP signaling through integrated inputs into the Smadl linker. Mol Cell 25:441-154.
68. Nakayama K, Tamura Y, Suzawa M, Harada S, Fukumoto S, Kato M, Miyazono K, Rodan GA, Takeuchi Y, Fujita T 2003 Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-El osteoblast-like cells. J Bone Miner Res 18:827-835.
69. Hu MC, Rosenblum ND 2005 Smadl, ß-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 132:215-225.
70. Labbe E, Letamendia A, Attisano L 2000 Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-fi and wnt pathways. Proc Natl Acad Sci USA 97:8358-8363.
71. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G 2001 Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation. Bone 29:323-330.
72. Zhao M, Qiao M, Harris SE, Chen D, Oyajobi BO, Mundy GR 2006 The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol Cell Biol 26:6197-6208.
73. Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN 2007 Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res 22:646-655.
74. Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K, Yamamura M, Makino H 2007 TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun 356:1004-1010.